Revolutionizing Drug Discovery with AI-Powered Innovation @InsilicoMedicine
Revolutionizing Drug Discovery with AI-Powered Innovation  @InsilicoMedicine
Uploaded February 2026 | Updated September 2026, 1 week ago
Nach01 is an innovative foundation model for drug discovery that uniquely combines natural language processing with advanced chemical intelligence. By integrating text-based chemical representations and 3D molecular structures through its dual-component architecture - LLM component (supporting textual reasoning in chemical science) and PC-Encoder (featuring spatial awareness) - the system delivers robust, high-quality performance in molecular property prediction and generative design tasks.
Revolutionizing Drug Discovery with AI-Powered InnovationBenchmark DiscoveryAI-powered Drug Discovery lecture by Dr. Michael Levitt, 2013 Nobel Laureate in ChemistryInsilico Medicines first AI-discovered antifibrotic drug goes first-in-humanIntroducing nach0: A one-stop LLM for chemical and biomedical tasksO3DC - Open Drug Discovery and Development Consortium. Hear from the Experts.Insilico Deployed the First Bipedal Humanoid at the AI-Powered Fully-Automated LabIntroduction of PandaOmics for Target Discovery in Amyotrophic Lateral Sclerosis patientsKOLs Interview Series: Dr. Charles CantorCGTN Live with Alex ZhavoronkovPandaOmics 3.0 - the tool for OMICS Data Analysis, Pathway Analysis and Visualization, and Target IDAI-Unleashed - Docuthon Honorable Mention
Insilico Medicine |

Revolutionizing Drug Discovery with AI-Powered Innovation

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER